Stage IV Squamous Cell Lung Carcinoma (DBCOND0044229)

Identifiers

Synonyms

Lung Squamous Cell Carcinoma Stage IV / Lung squamous cell carcinoma metastatic / Squamous cell carcinoma of lung stage IV

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT01115790	A Phase 1 Study in Participants With Advanced Cancer	Prexasertib	treatment	1	completed
NCT02831933	Trial of Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma and Uveal Melanoma	Nalotimagene carmaleucel Nivolumab Valaciclovir	treatment	2	terminated
NCT04306042	A Survival Observational Study in Patients With Advanced IIIB-IV Squamous Cell Lung Cancer Receiving PD-1 Combination With Chemotherapy	Nivolumab Pembrolizumab	Not Available	Not Available	unknown_status
NCT02785913	Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches	Taselisib	treatment	2	completed
NCT00946712	S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer	Bevacizumab Carboplatin Cetuximab Paclitaxel	treatment	3	terminated
NCT02536495	Selinexor and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Lung Cancer	Docetaxel Escitalopram Selinexor	treatment	1 / 2	withdrawn